{"schema_version":"1","generated_at":"2026-10-28T04:02:11.798Z","data_as_of":null,"url":"https://www.findmykol.com/kol/wade-thorstad","json_url":"https://www.findmykol.com/kol/wade-thorstad/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"wade-thorstad","name":"Wade Thorstad","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Washington University in St. Louis","institution_url":"https://www.findmykol.com/institution/washington-university-school-of-medicine-in-st-louis","city":"Saint Louis","state":"MO","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1356367668","orcid":"0000-0002-2757-0543","openalex":"A5072448404"},"summary":"Wade Thorstad is an Oncology physician affiliated with Washington University in St. Louis. OpenAlex indexes 758 publications with 13,227 citations (h-index 53); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Radiation Oncology profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":758,"cited_by_count":13227,"h_index":53,"latest_activity_year":2025,"citation_standing":{"top_percent":10,"cohort":"Radiation Oncology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":4,"shown":3,"withheld":5,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07552558","title":"Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)","phase":"PHASE1/PHASE2","status":"NOT_YET_RECRUITING","role":"Site investigator","sponsor":"Washington University School of Medicine","source_url":"https://clinicaltrials.gov/study/NCT07552558","trial_url":"https://www.findmykol.com/trial/NCT07552558"},{"nct":"NCT06702033","title":"The Minimalist Trial-2","phase":"PHASE2","status":"RECRUITING","role":"Site investigator","sponsor":"Washington University School of Medicine","source_url":"https://clinicaltrials.gov/study/NCT06702033","trial_url":"https://www.findmykol.com/trial/NCT06702033"},{"nct":"NCT04852328","title":"Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma","phase":"PHASE2","status":"RECRUITING","role":"Site investigator","sponsor":"Washington University School of Medicine","source_url":"https://clinicaltrials.gov/study/NCT04852328","trial_url":"https://www.findmykol.com/trial/NCT04852328"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Tactile Systems Technology Inc","program_year":2025,"amount_usd":158.57,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356367668"},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2025,"amount_usd":54.66,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356367668"},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2024,"amount_usd":17.96,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356367668"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1356367668","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":42.8,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":42.8,"drugs":[{"name":"Fentanyl","share_pct":57.3},{"name":"Oxycodone Hcl","share_pct":42.7}],"max_beneficiaries":18}]},{"area":"Cardiovascular","share_pct":24.8,"classes_total":1,"classes":[{"class":"Antiarrhythmic","setting":"prescribed","share_pct":24.8,"drugs":[{"name":"Lidocaine Hcl Viscous","share_pct":100}],"max_beneficiaries":28}]},{"area":"Respiratory","share_pct":21.2,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":21.2,"drugs":[{"name":"Hydrocodone-Acetaminophen","share_pct":100}],"max_beneficiaries":26}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma","year":2023,"journal":"Nature Genetics","source_url":"https://doi.org/10.1038/s41588-023-01357-3","status":"verified"},{"title":"Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)","year":2021,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.20.03128","status":"verified"},{"title":"Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial","year":2020,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-20-1695","status":"verified"},{"title":"Management of primary skin cancer during a pandemic: Multidisciplinary recommendations","year":2020,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.32969","status":"verified"},{"title":"NRG-HN002: A Randomized Phase II Trial for Patients With p16-Positive, Non-Smoking-Associated, Locoregionally Advanced Oropharyngeal Cancer","year":2019,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2019.08.038","status":"verified"}],"source":"works"},"contact":{"address_1":"4921 PARKVIEW PL","address_2":"DEPT RADIATION ONCOLOGY, LL","city":"Saint Louis","state":"MO","zip":"631101032","phone":"314-747-7236","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1356367668","source":"identity"},"similar":[{"name":"Randall Bateman","slug":"randall-bateman","institution":"Washington University in St. Louis","specialty":"Neurology","url":"https://www.findmykol.com/kol/randall-bateman","json_url":"https://www.findmykol.com/kol/randall-bateman/profile.json"},{"name":"Janet McGill","slug":"janet-mcgill","institution":"Washington University in St. Louis","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/janet-mcgill","json_url":"https://www.findmykol.com/kol/janet-mcgill/profile.json"},{"name":"Robert Carney","slug":"robert-carney","institution":"Washington University in St. Louis","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/robert-carney","json_url":"https://www.findmykol.com/kol/robert-carney/profile.json"},{"name":"David Clifford","slug":"david-clifford","institution":"Washington University in St. Louis","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-clifford","json_url":"https://www.findmykol.com/kol/david-clifford/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":5,"payments":1,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-04-17","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}